SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: A clue to the histogenesis for tumor diagnosis

Modern Pathology

Volumn 26, Issue 8, 2013, Pages 1041-1050

  Ohtomo, Rie ^a   Mori, Taisuke ^b   Shibata, Shinsuke ^c   Tsuta, Koji ^a   Maeshima, Akiko M ^a   Akazawa, Chihiro ^d   Watabe, Yukio ^b   Honda, Kazufumi ^b   Yamada, Tesshi ^b   Yoshimoto, Seiichi ^a   Asai, Masao ^a   Okano, Hideyuki ^c   Kanai, Yae ^b   Tsuda, Hitoshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

p63; Salivary gland development; Salivary gland tumor; SOX10

Indexed keywords

PROTEIN P63; PROTEIN S 100; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR SOX10;

ACINAR CELL; ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MORPHOLOGY; CELL DIFFERENTIATION; CONTROLLED STUDY; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOUSE; MYOEPITHELIOMA; MYOEPITHELIUM CELL; NONHUMAN; ONCOCYTOMA; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SALIVARY GLAND DUCT; SALIVARY GLAND TUMOR; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TUMOR DIAGNOSIS; WARTHIN TUMOR;

ACINAR CELLS; ADENOMA; ANIMALS; CARCINOMA; CELL DIFFERENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; SOXE TRANSCRIPTION FACTORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84881312645     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.54     Document Type: Article

References (21)

1. Kelsh RN. Sorting out SOX10 functions in neural crest development. Bioessays 2006;28:788-798.
2. Nonaka D, Chiriboga L, Rubin BP. SOX10: A panschwannian and melanocytic marker. Am J Surg Pathol 2008;32:1291-1298.
3. Roh J, Cho EA, Seong I, et al. Down-regulation of SOX10 with specific small interfering RNA promotes transdifferentiation of Schwannoma cells into myofibroblasts. Differentiation 2006;74:542-551.
4. Knox SM, Hoffman MP. Salivary gland development and regeneration, In: Wong DT(eds). Salivary Diagnostics. Wiley-Blackwell: Ames, 2008, pp 3-13.
5. Lombaert IMA, Hoffman MP. Epithelial stem/progenitor cells in the embryonic mouse submandibular gland, In: Tucker AS, Miletich I (eds). Salivary Glands; Development, Adaptation and Disease. Vol. 14 Karger: Basel, 2010, pp 90-106.
6. Deal KK, Cantrell VA, Chandler RL, et al. Distant regulatory elements in a SOX10-beta GEO BAC transgene are required for expression of SOX10 in the enteric nervous system and other neural crest-derived tissues. Dev Dyn 2006;235:1413-1432.
7. Eveson JW, Auclair P, Gnepp DR, et al. World Health Organization Classification of Tumours, Pathology and Genetics of Head and Neck Tumours, Chapter 5. Tumors of the salivary glands. IARC Press: Lyon, 2005, pp 209-215.
8. Yamamoto S, Tsuda H, Honda K, et al. Actinin-4 expression in ovarian cancer: A novel prognostic indicator independent of clinical stage and histological type. Mod Pathol 2007;20:1278-1285.
9. Effendi K, Mori T, Komuta M, et al. Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression. Cancer Sci 2010;101:666-672.
10. Mori T, Kiyono T, Imabayashi H, et al. Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol Cell Biol 2005;25:5183-5195.
11. Shibata S, Yasuda A, Renault-Mihara F, et al. SOX10-Venus mice: A new tool for real-time labeling of neural crest lineage cells and oligodendrocytes. Mol Brain 2010;3:31.
12. Ianez RF, Buim ME, Coutinho-Camillo CM, et al. Human salivary gland morphogenesis: Myoepithelial cell maturation assessed by immunohistochemical markers. Histopathology 2010;57:410-417.
13. Dardick I. Color Atlas/Text of Salivary Gland Tumor Pathology. Igaku-shoin medical Publishers: New York; 1996, pp 7-16.
14. Gillespie MB, Albergotti WG, Eisele DW. Recurrent salivary gland cancer. Curr Treat Options Oncol 2012;13:58-70.
15. Chênevert J, Duvvuri U, Chiosea S, et al. DOG1: A novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol 2012;25:919-929.
16. Prasad AR, Savera AT, Gown AM, et al. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med 1999;123: 801-806.
17. Okura M, Hiranuma T, Tominaga G, et al. Expression of S-100 protein and glial fibrillary acidic protein in cultured submandibular gland epithelial cells and salivary gland tissues. Histogenetic implication for salivary gland tumors. Am J Pathol 1996;148:1709-1716.
18. Weinreb I, Seethala RR, Hunt JL, et al. Intercalated duct lesions of salivary gland: A morphologic spectrum from hyperplasia to adenoma. Am J Surg Pathol 2009;33:1322-1329.
19. Burlage FR, Faber H, Kampinga HH, et al. Coppes RP.Enhanced proliferation of acinar and progenitor cells by prophylactic pilocarpine treatment underlies the observed amelioration of radiation injury to parotid glands. Radiother Oncol 2009;90:253-256.
20. Chetty R. Intercalated duct hyperplasia: Possible relationship to epithelial-myoepithelial carcinoma and hybrid tumours of salivary gland. Histopathology 2000;37:260-263.
21. Shakhova O, Zingg D, Schaefer SM, et al. SOX10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol 2012; 14:882-890.